As with all marketing authorisation applications, before Exubera is granted a licence and becomes available in the United Kingdom it must be fully evaluated in relation to the appropriate standards required in the relevant European rules and
453W
regulations on medicinal products. Data submitted in support of the application will need to demonstrate that the safety, quality and efficacy of the product are satisfactory for its intended use.